|
Recent Developments |
|
19-MAR-08
Fem Care Pharma announced that the equity shareholders of the company approved the scheme of amalgamation between Mirasu Marketing with the company and their respective shareholders.
Future Plans
Fem is planing to make a substantial investment in R&D in coming years. A full-fledged independent R&D activity will be undertaken in an area of 8000 sq ft under an expansion plan. The company`s focus will b... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2010 (12) | 31-Mar-2009 (12) | 31-Mar-2008 (12) | | Net sales | 1191.68 | 1074.71 | 937.51 | | Other Income | 57.26 | 24.62 | 11.12 | | Total Income | 1248.94 | 1099.33 | 948.63 | | Cost of goods sold | 987.00 | 909.03 | 836.56 | | OPBDIT | 261.94 | 190.30 | 112.07 | | PAT | 186.99 | 119.38 | 45.96 | | Gross Block | - | - | - | | Equity capital | 35.31 | 35.31 | 30.10 | | EPS (Rs.) | 52.98 | 0.00 | 13.02 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | 10.19 - 16.15 | NA | 19.20 - 42.24 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 21.0 | 17.3 | 11.8 | | Net margin (% of OI) | 15.0 | 10.9 | 4.8 |
|
|
Detailed Financials
|
|
|
|
|
